Evidence map›Paper›PMID 29760956›Full record

ArticleCell death discovery2018

BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis.

Tim Vervliet, Julia V Gerasimenko, Pawel E Ferdek, Monika A Jakubowska, Ole H Petersen, Oleg V Gerasimenko, Geert Bultynck

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death discovery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. The role of CaCell calcium · 2023
    Review
  5. Physiological and pharmacological modulation of BAX.Trends in pharmacological sciences · 2022
    Review
  6. Bcl-2-Protein Family as Modulators of IPCold Spring Harbor perspectives in biology · 2020
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Tim Vervliet *1Department of Cellular and Molecular Medicine, Laboratory of Molecular and Cellular Signaling, KU Leuven, Leuven, 3000 Belgium.
Julia V Gerasimenko *2Medical Research Council Group, Cardiff School of Biosciences, Cardiff University, Cardiff, CF10 3AX UK.
Pawel E Ferdek2Medical Research Council Group, Cardiff School of Biosciences, Cardiff University, Cardiff, CF10 3AX UK.
Monika A Jakubowska2Medical Research Council Group, Cardiff School of Biosciences, Cardiff University, Cardiff, CF10 3AX UK.
Ole H Petersen2Medical Research Council Group, Cardiff School of Biosciences, Cardiff University, Cardiff, CF10 3AX UK.
Oleg V Gerasimenko2Medical Research Council Group, Cardiff School of Biosciences, Cardiff University, Cardiff, CF10 3AX UK.
Geert Bultynck1Department of Cellular and Molecular Medicine, Laboratory of Molecular and Cellular Signaling, KU Leuven, Leuven, 3000 Belgium.
Medical Research Council · GBCardiff University · GBVIB-KU Leuven Center for Cancer Biology · BE

Funding

Medical Research Council MR/J002771/1
6 · The paper itself

Abstract

Biliary acute pancreatitis (AP) is a serious condition, which currently has no specific treatment. Taurolithocholic acid 3-sulfate (TLC-S) is one of the most potent bile acids causing cytosolic Ca

Identifiers

PMID29760956
PMCPMC5945673
OpenAlexW2800653328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.